Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The 'Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report By Type (Viral, Bacterial, Combination), By Age Group, By Infection (COVID-19, Influenza), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030' report has been added to ResearchAndMarkets.com's offering.The global respiratory disease vaccine market size is expected to reach USD 70.30 billion by 2030, expanding at a CAGR of 1.21% from 2023 to 2030 The growth of the respiratory disease vaccine market is attributable to increasing awareness associated with the importance of vaccination, the rising incidence of respiratory infections, and advancements in vaccine technology.

都柏林，2023年12月12日（环球通讯社）——ResearchAndMarkets.com发布了“2023-2030年呼吸道疾病疫苗市场规模、份额和趋势分析报告（按类型（病毒、细菌、组合）、年龄组、感染（COVID-19，流感）、分销渠道、地区和细分市场预测”。预计到2030年，全球呼吸道疾病疫苗市场规模将达到703.0亿美元，从2023年到2030年，复合年增长率将达到1.21%。呼吸道疾病疫苗市场的增长归因于人们对疫苗接种重要性的认识提高，呼吸道感染发病率上升以及疫苗技术的进步。

Moreover, the COVID-19 pandemic has brought significant traction to the importance of respiratory vaccines which has further accelerated the market.Respiratory vaccines, particularly those targeting influenza and pneumonia, are vital in reducing the burden on healthcare systems and minimizing the risk of co-infections with COVID-19.

此外，新型冠状病毒肺炎大流行对呼吸道疫苗的重要性产生了重大影响，这进一步加速了市场的发展。呼吸道疫苗，特别是针对流感和肺炎的疫苗，对于减轻医疗保健系统的负担和最大程度地降低与新型冠状病毒共感染的风险至关重要。

In order to prevent the spread of the virus and prevent the occurrence of outbreaks healthcare providers have been focusing on vaccination to protect individuals against respiratory pathogens like influenza. In recent years, the respiratory vaccine market has witnessed substantial growth attributed to advancements in vaccine technology, specifically in the development of vaccines targeting SARS-CoV-2.

为了防止病毒传播并防止爆发，医疗保健提供者一直专注于接种疫苗，以保护个人免受流感等呼吸道病原体的侵害。近年来，由于疫苗技术的进步，特别是针对SARS-CoV-2的疫苗的开发，呼吸道疫苗市场出现了大幅增长。

The successful development, approval, and deployment of COVID-19 vaccines have demonstrated the capacity of the scientific community to respond rapidly to respiratory threats and have paved the way for future advancements in respiratory vaccine research and development.Moreover, government backing and surveillance at both national and globa.

新型冠状病毒肺炎疫苗的成功开发，批准和部署证明了科学界快速应对呼吸道威胁的能力，并为呼吸道疫苗研究和开发的未来进步铺平了道路。此外，国家和全球的政府支持和监督。